av/novartis--big.svg

COM:NOVARTIS

Novartis

  • Stock

Last Close

91.56

22/11 16:30

Market Cap

193.82B

Beta: -

Volume Today

3.74M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
58.83B
-
53.63B
8.83%
50.39B
6.05%
49.44B
1.89%
50.13B
1.41%
53.17B
6.05%
48.68B
8.44%
49.90B
2.51%
52.88B
5.97%
51.83B
1.98%
46.66B
9.97%
cost of revenue
19.61B
-
17.34B
11.54%
17.40B
0.34%
17.52B
0.67%
17.18B
1.97%
18.41B
7.17%
14.43B
21.63%
15.12B
4.82%
15.87B
4.93%
15.49B
2.40%
12.47B
19.46%
gross profit
39.22B
-
36.29B
7.48%
32.98B
9.11%
31.92B
3.23%
32.96B
3.27%
34.76B
5.46%
34.25B
1.46%
34.78B
1.53%
37.01B
6.42%
36.34B
1.80%
34.19B
5.93%
selling and marketing expenses
14.55B
-
12.38B
14.93%
11.77B
4.89%
12.00B
1.92%
12.86B
7.19%
general and administrative expenses
3.06B
-
2.62B
14.51%
2.48B
5.39%
2.19B
11.35%
2.14B
2.64%
selling general and administrative expenses
17.61B
-
14.99B
14.86%
14.25B
4.98%
14.19B
0.39%
15.00B
5.67%
16.47B
9.83%
14.37B
12.76%
14.20B
1.20%
14.89B
4.85%
14.25B
4.25%
12.52B
12.18%
research and development expenses
9.85B
-
9.09B
7.78%
8.94B
1.66%
9.04B
1.16%
8.97B
0.74%
9.07B
1.14%
9.40B
3.61%
8.98B
4.49%
9.54B
6.24%
10.00B
4.78%
11.37B
13.76%
other expenses
852M
-
1.12B
31.57%
824M
26.49%
417M
49.39%
362M
13.19%
1.04B
188.67%
1.40B
33.49%
1.45B
3.80%
895M
38.19%
2.90B
223.58%
cost and expenses
47.92B
-
42.55B
11.22%
41.41B
2.67%
41.17B
0.58%
41.51B
0.82%
45.00B
8.41%
39.59B
12.01%
39.75B
0.39%
41.19B
3.63%
42.63B
3.50%
36.89B
13.46%
operating expenses
28.31B
-
25.20B
10.99%
24.01B
4.74%
23.65B
1.49%
24.33B
2.89%
26.59B
9.28%
25.17B
5.36%
24.63B
2.15%
25.32B
2.83%
27.14B
7.20%
24.42B
10.04%
interest expense
683M
-
704M
3.07%
655M
6.96%
707M
7.94%
777M
9.90%
957M
23.17%
850M
11.18%
869M
2.24%
811M
6.67%
837M
3.21%
855M
2.15%
ebitda
16.41B
-
17.73B
8.04%
14.36B
18.97%
15.04B
4.69%
15.90B
5.72%
21.75B
36.82%
15.62B
28.20%
17.21B
10.21%
33.06B
92.09%
16.39B
50.43%
18.47B
12.69%
operating income
10.91B
-
11.09B
1.64%
8.98B
19.05%
8.27B
7.90%
8.63B
4.37%
8.17B
5.33%
9.09B
11.23%
10.15B
11.73%
26.95B
165.45%
9.20B
65.87%
9.77B
6.22%
depreciation and amortization
4.99B
-
4.75B
4.79%
5.58B
17.34%
6.04B
8.39%
6.08B
0.55%
6.89B
13.43%
6.53B
5.25%
7.06B
8.10%
6.11B
13.40%
7.19B
17.65%
8.28B
15.09%
total other income expenses net
600M
-
1.92B
219.67%
266M
86.13%
233M
12.41%
1.06B
356.22%
6.37B
499.44%
-146M
102.29%
-274M
87.67%
-811M
195.99%
-826M
1.85%
-227M
72.52%
income before tax
10.73B
-
12.27B
14.32%
8.13B
33.72%
7.82B
3.90%
9.00B
15.12%
13.84B
53.74%
8.94B
35.38%
9.88B
10.49%
26.14B
164.60%
8.37B
67.97%
9.12B
8.98%
income tax expense
1.44B
-
1.54B
7.07%
1.11B
28.41%
1.12B
1.18%
1.30B
15.82%
1.22B
5.79%
1.79B
46.85%
1.81B
0.78%
2.12B
17.27%
1.42B
33.18%
551M
61.09%
net income
9.18B
-
10.21B
11.28%
17.78B
74.17%
6.71B
62.26%
7.70B
14.76%
12.61B
63.72%
7.15B
43.33%
8.07B
12.94%
24.02B
197.58%
6.96B
71.05%
14.85B
113.52%
weighted average shs out
2.44B
-
2.43B
0.61%
2.40B
0.95%
2.38B
1.04%
2.35B
1.35%
2.32B
1.15%
2.29B
1.21%
2.28B
0.61%
2.24B
1.49%
2.18B
2.76%
weighted average shs out dil
2.48B
-
2.47B
0.36%
2.44B
1.30%
2.40B
1.56%
2.37B
1.21%
2.34B
1.14%
2.32B
1.07%
2.30B
0.99%
2.26B
1.57%
2.20B
2.79%
eps
3.76
-
4.21
11.97%
7.40
75.77%
2.82
61.89%
3.28
16.31%
5.44
65.85%
3.12
42.65%
3.55
13.78%
10.71
201.69%
3.19
70.21%
0
100%
epsdiluted
3.70
-
4.13
11.62%
7.29
76.51%
2.80
61.59%
3.25
16.07%
5.38
65.54%
3.08
42.75%
3.52
14.29%
10.63
201.99%
3.17
70.18%
0
100%

All numbers in (except ratios and percentages)